originally published on may 17, 2018 10:46 pm.
.
erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the.![]()
.
may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful.![]()
.
november 17, 2014..